Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00482963 · ClinicalTrials.gov registry record · Phase 1
A Study of the Drug Interactions Between a Hormonal Emergency Contraception and an HIV Medication
A Phase 1 study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT00482963 is a Phase 1 study that has completed, run by University of Colorado, Denver. The registered enrollment target is 24 participants.
The verdict
NCT00482963, a Phase 1 study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if blood levels of the hormonal emergency contraceptive agent, Plan B, are altered by concomitant use with the HIV medication, efavirenz.
Interventions
- DRUG levonorgestrel, efavirenz
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2007-05 |
| Est. Completion | 2008-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00482963
The ClinicalTrials.gov registry entry for NCT00482963 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which levonorgestrel, efavirenz is the first listed.
NCT00482963 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00482963 about?
NCT00482963 is a clinical study titled "A Study of the Drug Interactions Between a Hormonal Emergency Contraception and an HIV Medication". The purpose of this study is to determine if blood levels of the hormonal emergency contraceptive agent, Plan B, are altered by concomitant use with the HIV medication, efavirenz.
What is the current status of trial NCT00482963?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2007-05. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00482963?
The interventions under investigation include: levonorgestrel, efavirenz (DRUG).
Who is sponsoring clinical trial NCT00482963?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.